ETIHX
Price
$30.95
Change
+$0.38 (+1.24%)
Updated
May 8 closing price
Net Assets
1.03B
FSPHX
Price
$25.23
Change
-$0.05 (-0.20%)
Updated
May 8 closing price
Net Assets
6.2B
Ad is loading...

ETIHX vs FSPHX

Header iconETIHX vs FSPHX Comparison
Open Charts ETIHX vs FSPHXBanner chart's image
Eventide Healthcare & Life Sciences I
Price$30.95
Change+$0.38 (+1.24%)
VolumeN/A
Net Assets1.03B
Fidelity Select Health Care
Price$25.23
Change-$0.05 (-0.20%)
VolumeN/A
Net Assets6.2B
ETIHX vs FSPHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ETIHX vs. FSPHX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETIHX is a Buy and FSPHX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.2B vs. ETIHX (1.03B). FSPHX pays higher dividends than ETIHX: FSPHX (0.02) vs ETIHX (0.00). ETIHX was incepted earlier than FSPHX: ETIHX (12 years) vs FSPHX (44 years). ETIHX (1.32) is less costly to investors than FSPHX (0.63). ETIHX is a more actively managed with annual turnover of: 71.00 vs. FSPHX (40.00). FSPHX has a lower initial minimum investment than ETIHX: FSPHX (0) vs ETIHX (100000). FSPHX annual gain was more profitable for investors over the last year : -11.31 vs. ETIHX (-13.89). FSPHX return over 5 years is better than : -11.47 vs. ETIHX (-20.21).
ETIHXFSPHXETIHX / FSPHX
Total Expense Ratio1.320.63210%
Annual Report Gross Expense Ratio1.320.63210%
Fund Existence12 years44 years-
Gain YTD-8.088-7.229112%
Front LoadN/AN/A-
Min. Initial Investment1000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.03B6.2B17%
Annual Yield % from dividends0.000.02-
Returns for 1 year-13.89-11.31123%
Returns for 3 years28.825.18557%
Returns for 5 years-20.21-11.47176%
Returns for 10 years27.778.19339%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMPEX24.910.38
+1.55%
Beck Mack + Oliver Partners
WBENX12.40N/A
N/A
William Blair Emerging Mkts Growth N
IJSIX14.82N/A
N/A
VY® JPMorgan Small Cap Core Equity I
VMACX56.24N/A
N/A
Virtus KAR Mid-Cap Core A
AULYX91.91N/A
N/A
American Century Ultra® Y